Table of Content

1. Introduction


2. Research & Methodology


3. Executive Summary


4. Market Dynamics

4.1 Growth Drivers
4.2 Challenges


5. Global Liver Disease Market


6. Market Share – Global Liver Disease Market

6.1 By Treatment Type
6.2 By Disease type
6.3 By End Use
6.4 By Region


7. Treatment Type – Global Liver Disease Market

7.1 Antiviral Drugs
7.2 Immunosuppressants
7.3 Vaccines
7.4 Immunoglobulins
7.5 Corticosteriods
7.6 Targeted Therapy
7.7 Chemotherapy


8. Disease Type – Global Liver Disease Market

8.1 Hepatitis
8.2 Autoimmune Diseases
8.3 Non-alcoholic Fatty Liver Disease
8.4 Cancer
8.5 Genetic Disorders
8.6 Others


9. End Use – Global Liver Disease Market

9.1 Hospitals
9.2 Ambulatory Surgery Centers
9.3 Other


10. Region – Global Liver Disease Market

10.1 North America
10.2 Europe
10.3 Asia Pacific
10.4 Latin America, Middle East and Africa (LAMEA)


11. Company Analysis

11.1 Abbott Laboratories

11.1.1 Overview
11.1.2 Recent Development
11.1.3 Financial Insights

11.2 Eli Lilly

11.2.1 Overview
11.2.2 Recent Development
11.2.3 Financial Insights

11.3 Sanofi

11.3.1 Overview
11.3.2 Recent Development
11.3.3 Financial Insights

11.4 Johnson & Johnson

11.4.1 Overview
11.4.2 Recent Development
11.4.3 Financial Insights

11.5 Bristol Myers Squibb Co.

11.5.1 Overview
11.5.2 Recent Development
11.5.3 Financial Insights

11.6 Merck & Co. Inc.

11.6.1 Overview
11.6.2 Recent Development
11.6.3 Financial Insights

11.7 Bayer AG

11.7.1 Overview
11.7.2 Recent Development
11.7.3 Financial Insights



List of Figures

Figure-01: Global – Liver Disease Market (Billion US$), 2016 – 2022
Figure-02: Global – Forecast for Liver Disease Market (Billion US$), 2023 – 2027
Figure-03: Treatment Type – Antiviral Drugs Market (Million US$), 2016 – 2022
Figure-04: Treatment Type – Forecast for Antiviral Drugs Market (Million US$), 2023 – 2027
Figure-05: Treatment Type – Immunosuppressants Market (Million US$), 2016 – 2022
Figure-06: Treatment Type – Forecast for Immunosuppressants Market (Million US$), 2023 – 2027
Figure-07: Treatment Type – Vaccines Market (Million US$), 2016 – 2022
Figure-08: Treatment Type – Forecast for Vaccines Market (Million US$), 2023 – 2027
Figure-09: Treatment Type – Immunoglobulins Market (Million US$), 2016 – 2022
Figure-10: Treatment Type – Forecast for Immunoglobulins Market (Million US$), 2023 – 2027
Figure-11: Treatment Type – Corticosteriods Market (Million US$), 2016 – 2022
Figure-12: Treatment Type – Forecast for Corticosteriods Market (Million US$), 2023 – 2027
Figure-13: Treatment Type – Targeted Therapy Market (Million US$), 2016 – 2022
Figure-14: Treatment Type – Forecast for Targeted Therapy Market (Million US$), 2023 – 2027
Figure-15: Treatment Type – Chemotherapy Market (Million US$), 2016 – 2022
Figure-16: Treatment Type – Forecast for Chemotherapy Market (Million US$), 2023 – 2027
Figure-17: Disease Type – Hepatitis Market (Million US$), 2016 – 2022
Figure-18: Disease Type – Forecast for Hepatitis Market (Million US$), 2023 – 2027
Figure-19: Disease Type – Autoimmune Diseases Market (Million US$), 2016 – 2022
Figure-20: Disease Type – Forecast for Autoimmune Diseases Market (Million US$), 2023 – 2027
Figure-21: Disease Type – Non-alcoholic Fatty Liver Disease Market (Million US$), 2016 – 2022
Figure-22: Disease Type – Forecast for Non-alcoholic Fatty Liver Disease Market (Million US$), 2023 – 2027
Figure-23: Disease Type – Cancer Market (Million US$), 2016 – 2022
Figure-24: Disease Type – Forecast for Cancer Market (Million US$), 2023 – 2027
Figure-25: Disease Type – Genetic Disorders Market (Million US$), 2016 – 2022
Figure-26: Disease Type – Forecast for Genetic Disorders Market (Million US$), 2023 – 2027
Figure-27: Disease Type – Others Market (Million US$), 2016 – 2022
Figure-28: Disease Type – Forecast for Others Market (Million US$), 2023 – 2027
Figure-29: End Use – Hospitals Market (Million US$), 2016 – 2022
Figure-30: End Use – Forecast for Hospitals Market (Million US$), 2023 – 2027
Figure-31: End Use – Ambulatory Surgery Centers Market (Million US$), 2016 – 2022
Figure-32: End Use – Forecast for Ambulatory Surgery Centers Market (Million US$), 2023 – 2027
Figure-33: End Use – Other Market (Million US$), 2016 – 2022
Figure-34: End Use – Forecast for Other Market (Million US$), 2023 – 2027
Figure-35: North America – Liver Disease Market (Million US$), 2016 – 2022
Figure-36: North America – Forecast for Liver Disease Market (Million US$), 2023 – 2027
Figure-37: Europe – Liver Disease Market (Million US$), 2016 – 2022
Figure-38: Europe – Forecast for Liver Disease Market (Million US$), 2023 – 2027
Figure-39: Asia Pacific – Liver Disease Market (Million US$), 2016 – 2022
Figure-40: Asia Pacific – Forecast for Liver Disease Market (Million US$), 2023 – 2027
Figure-41: Latin America, Middle East and Africa – Liver Disease Market (Million US$), 2016 – 2022
Figure-42: Latin America, Middle East and Africa – Forecast for Liver Disease Market (Million US$), 2023 – 2027
Figure-43: Abbott Laboratories – Global Revenue (Billion US$), 2016 – 2022
Figure-44: Abbott Laboratories – Forecast for Global Revenue (Billion US$), 2023 – 2027
Figure-45: Eli Lilly – Global Revenue (Billion US$), 2016 – 2022
Figure-46: Eli Lilly – Forecast for Global Revenue (Billion US$), 2023 – 2027
Figure-47: Sanofi – Global Revenue (Billion US$), 2016 – 2022
Figure-48: Sanofi – Forecast for Global Revenue (Billion US$), 2023 – 2027
Figure-49: Johnson & Johnson – Global Revenue (Billion US$), 2016 – 2022
Figure-50: Johnson & Johnson – Forecast for Global Revenue (Billion US$), 2023 – 2027
Figure-51: Bristol Myers Squibb Co. – Global Revenue (Billion US$), 2016 – 2022
Figure-52: Bristol Myers Squibb Co. – Forecast for Global Revenue (Billion US$), 2023 – 2027
Figure-53: Merck & Co. Inc. – Global Revenue (Billion US$), 2016 – 2022
Figure-54: Merck & Co. Inc. – Forecast for Global Revenue (Billion US$), 2023 – 2027
Figure-55: Bayer AG – Global Revenue (Billion US$), 2016 – 2022
Figure-56: Bayer AG – Forecast for Global Revenue (Billion US$), 2023 – 2027

List of Tables

Table-01: Global – Liver Disease Market Share by Treatment Type (Percent), 2016 – 2022
Table-02: Global – Forecast for Liver Disease Market Share by Treatment Type (Percent), 2023 – 2027
Table-03: Global – Liver Disease Market Share by Disease Type (Percent), 2016 – 2022
Table-04: Global – Forecast for Liver Disease Market Share by Disease Type (Percent), 2023 – 2027
Table-05: Global – Liver Disease Market Share by End Use (Percent), 2016 – 2022
Table-06: Global – Forecast for Liver Disease Market Share by End Use (Percent), 2023 – 2027
Table-07: Global – Liver Disease Market Share by Region (Percent), 2016 – 2022
Table-08: Global – Forecast for Liver Disease Market Share by Region (Percent), 2023 – 2027